BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 36412164)

  • 21. Test-retest repeatability of a deep learning architecture in detecting and segmenting clinically significant prostate cancer on apparent diffusion coefficient (ADC) maps.
    Hiremath A; Shiradkar R; Merisaari H; Prasanna P; Ettala O; Taimen P; Aronen HJ; Boström PJ; Jambor I; Madabhushi A
    Eur Radiol; 2021 Jan; 31(1):379-391. PubMed ID: 32700021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deep learning-assisted prostate cancer detection on bi-parametric MRI: minimum training data size requirements and effect of prior knowledge.
    Hosseinzadeh M; Saha A; Brand P; Slootweg I; de Rooij M; Huisman H
    Eur Radiol; 2022 Apr; 32(4):2224-2234. PubMed ID: 34786615
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiparametric MRI in detection and staging of prostate cancer.
    Boesen L
    Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Joint Prostate Cancer Detection and Gleason Score Prediction in mp-MRI via FocalNet.
    Cao R; Mohammadian Bajgiran A; Afshari Mirak S; Shakeri S; Zhong X; Enzmann D; Raman S; Sung K
    IEEE Trans Med Imaging; 2019 Nov; 38(11):2496-2506. PubMed ID: 30835218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimal Method for Reporting Prostate Cancer Grade in MRI-targeted Biopsies.
    Deng FM; Isaila B; Jones D; Ren Q; Kyung P; Hoskoppal D; Huang H; Mirsadraei L; Xia Y; Melamed J
    Am J Surg Pathol; 2022 Jan; 46(1):44-50. PubMed ID: 34115670
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Co-trained convolutional neural networks for automated detection of prostate cancer in multi-parametric MRI.
    Yang X; Liu C; Wang Z; Yang J; Min HL; Wang L; Cheng KT
    Med Image Anal; 2017 Dec; 42():212-227. PubMed ID: 28850876
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Head-to-head comparison of biparametric versus multiparametric MRI of the prostate before robot-assisted transperineal fusion prostate biopsy.
    Thaiss WM; Moser S; Hepp T; Kruck S; Rausch S; Scharpf M; Nikolaou K; Stenzl A; Bedke J; Kaufmann S
    World J Urol; 2022 Oct; 40(10):2431-2438. PubMed ID: 35922717
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of prostate cancer prognostic Gleason grade group using zonal-specific features extracted from biparametric MRI using a KNN classifier.
    Jensen C; Carl J; Boesen L; Langkilde NC; Østergaard LR
    J Appl Clin Med Phys; 2019 Feb; 20(2):146-153. PubMed ID: 30712281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Computer aided detection in prostate cancer diagnostics: A promising alternative to biopsy? A retrospective study from 104 lesions with histological ground truth.
    Thon A; Teichgräber U; Tennstedt-Schenk C; Hadjidemetriou S; Winzler S; Malich A; Papageorgiou I
    PLoS One; 2017; 12(10):e0185995. PubMed ID: 29023572
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MRI grading for the prediction of prostate cancer aggressiveness.
    Boschheidgen M; Schimmöller L; Arsov C; Ziayee F; Morawitz J; Valentin B; Radke KL; Giessing M; Esposito I; Albers P; Antoch G; Ullrich T
    Eur Radiol; 2022 Apr; 32(4):2351-2359. PubMed ID: 34748064
    [TBL] [Abstract][Full Text] [Related]  

  • 31. WeGleNet: A weakly-supervised convolutional neural network for the semantic segmentation of Gleason grades in prostate histology images.
    Silva-Rodríguez J; Colomer A; Naranjo V
    Comput Med Imaging Graph; 2021 Mar; 88():101846. PubMed ID: 33485056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autosegmentation of Prostate Zones and Cancer Regions from Biparametric Magnetic Resonance Images by Using Deep-Learning-Based Neural Networks.
    Lai CC; Wang HK; Wang FN; Peng YC; Lin TP; Peng HH; Shen SH
    Sensors (Basel); 2021 Apr; 21(8):. PubMed ID: 33921451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Going deeper through the Gleason scoring scale: An automatic end-to-end system for histology prostate grading and cribriform pattern detection.
    Silva-Rodríguez J; Colomer A; Sales MA; Molina R; Naranjo V
    Comput Methods Programs Biomed; 2020 Oct; 195():105637. PubMed ID: 32653747
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deep Learning-Based Gleason Grading of Prostate Cancer From Histopathology Images-Role of Multiscale Decision Aggregation and Data Augmentation.
    Karimi D; Nir G; Fazli L; Black PC; Goldenberg L; Salcudean SE
    IEEE J Biomed Health Inform; 2020 May; 24(5):1413-1426. PubMed ID: 31567104
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MRI-based prostate cancer classification using 3D efficient capsule network.
    Li Y; Wynne J; Wang J; Roper J; Chang CW; Patel AB; Shelton J; Liu T; Mao H; Yang X
    Med Phys; 2024 Feb; ():. PubMed ID: 38346111
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Automated deep-learning system for Gleason grading of prostate cancer using biopsies: a diagnostic study.
    Bulten W; Pinckaers H; van Boven H; Vink R; de Bel T; van Ginneken B; van der Laak J; Hulsbergen-van de Kaa C; Litjens G
    Lancet Oncol; 2020 Feb; 21(2):233-241. PubMed ID: 31926805
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bi- or multiparametric MRI in a sequential screening program for prostate cancer with PSA followed by MRI? Results from the Göteborg prostate cancer screening 2 trial.
    Wallström J; Geterud K; Kohestani K; Maier SE; Månsson M; Pihl CG; Socratous A; Arnsrud Godtman R; Hellström M; Hugosson J
    Eur Radiol; 2021 Nov; 31(11):8692-8702. PubMed ID: 33890152
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A direct comparison of contrast-enhanced ultrasound and dynamic contrast-enhanced magnetic resonance imaging for prostate cancer detection and prediction of aggressiveness.
    Baur ADJ; Schwabe J; Rogasch J; Maxeiner A; Penzkofer T; Stephan C; Rudl M; Hamm B; Jung EM; Fischer T
    Eur Radiol; 2018 May; 28(5):1949-1960. PubMed ID: 29238867
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biparametric Magnetic Resonance Imaging-Derived Nomogram to Detect Clinically Significant Prostate Cancer by Targeted Biopsy for Index Lesion.
    Kim MJ; Park SY
    J Magn Reson Imaging; 2022 Apr; 55(4):1226-1233. PubMed ID: 34296803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthetic magnetic resonance imaging for primary prostate cancer evaluation: Diagnostic potential of a non-contrast-enhanced bi-parametric approach enhanced with relaxometry measurements.
    Arita Y; Akita H; Fujiwara H; Hashimoto M; Shigeta K; Kwee TC; Yoshida S; Kosaka T; Okuda S; Oya M; Jinzaki M
    Eur J Radiol Open; 2022; 9():100403. PubMed ID: 35242886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.